Bio-Thera Solutions, Ltd.

Chinese biopharma developing biosimilars and novel antibody drugs

What Bio-Thera Solutions does

Bio-Thera Solutions is a Guangzhou-based drug company that develops and sells biologic medicines for cancer, autoimmune disorders, heart disease and eye disease. Many of its marketed products are biosimilars, which are lower-cost versions of well-known brand-name biologic drugs. It also has a large pipeline of new drug candidates in development.

How Bio-Thera Solutions makes money

It earns revenue from selling its approved biologic drugs in China and abroad. It also earns money through licensing and commercialization partnerships, such as its alliance with STADA for tocilizumab and its deal with Avalon Pharmaceuticals for Middle East and North Africa markets.

Products & services

• QLETLI (adalimumab biosimilar)
• POBEVCY (bevacizumab biosimilar)
• TOFIDENCE (tocilizumab biosimilar)
• BETAGRIN
• BAT5906 (wet AMD/DME, Phase III)
• BAT2406 (dupilumab biosimilar)